Updated employee announcements, business news, awards and recognition in the industry today.
People NewsSynteractHCR has appointed three new senior-level managers to its leadership team. They include: Heather Davis, Executive Director of US Project Management; Zia Haque, Executive Director, Clinical Data Management, and John Whitaker, PhD as Executive Director, Biostatistics. All will report to Marlo Vasquez, Vice President, US Operations.
Nordic life sciences investment company, Karolinska Development AB, has announced that company Chairman Bo Jesper Hansen, MD, PhD and CEO Jim Van huesden will step down from their respective positions. Current Deputy Chief Executive Officer and Chief Investment Officer Viktor Drvota, MD, PhD will be promoted as the company’s CEO.
Quanticate has appointed Praveen Dass as the new Global Head of India and Clinical Data Management.
Sam Herbert
Sam Herbert has assumed the role of president at World Courier, AmerisourceBergen following the retirement of longtime president John Butler at the end of March.
SAS has selected Linda Harpole, MD, MPH as its Chief Medical Officer. Harpole brings over 20 years of experience in academic and pharmaceutical industry research to this role.
WIRB-Copernicus Group announced the acquisition of MedAvante and ProPhase, and has named Jeffrey Litwin, MD as the CEO of the combined organization.
Rebecca Kush, PhD
PDS Life Sciences has appointed Vicente Nogués, PhD as Vice President of Product Development based in Basel, Switzerland.
Astellas partner Chromocell has appointed Heikki Mansikka, PhD as its new Medical Director.
Elligo Health Research has hired Rebecca Kush, PhD as the company’s Scientific Innovation Officer. Kush is the founder and former president and CEO of CDISC where she spent 20 years leading the development of global clinical research data standards to streamline clinical research.
RecognitionINC Research has become the first CRO to achieve the “Silver Standard” within the IAOCR Clinical Operations Workforce Quality Accreditation Program.
INC Research has been named to the 2017 CSO50 by IDG’s CSO magazine for the second consecutive year. The company was recognized this year for their cyber security training program for all employees worldwide.
Clintec has been awarded the Queens Award for Enterprise 2017 in the category of International Trade for the second time. This award is the highest accolade that can be granted to any business operating within the UK.
ICON plc has been included in Forbes magazine’s 2017 America’s Best Employers list. ICON was named as the highest ranking CRO in the best midsize employers listing.
Business NewsPPD announced the launch of its 2017 educational campaign to raise awareness for clinical research featuring its PPD Heroes, made up of individuals who have overcome illness with treatments developed through clinical research.
US Oncology Research enrolled more than 2,900 subjects into clinical trials during their fiscal year which ended March 31, 2017.
Cluepoints has expanded its operations in the US with the opening of its new office in Wayne, PA.
KCR has announced that it will expand its presence in the US market by relocating to new offices in Boston, MA.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.